Table 2.
The stability profile of sesamol-loaded NLCs
Initial | 1st Month | ||||||||
Size | PDI | ZP | EE% | DL% | Size | PDI | ZP | EE% | DL% |
92.3 ± 6.2 ± 1.2 | 0.23 ± 0.04 | −27.9 ± 0.5 | 94.2 ± 1.8 | 28.51 | 95.1 ± 4.9 | 0.19 ± 0.09 | −25.3 ± 0.3 | 92.7 ± 5.4 | 26.84 ± 1.7 |
3rd Month | 6th Month | ||||||||
Size | PDI | ZP | EE% | DL% | Size | PDI | ZP | EE% | DL% |
94.3 ± 4.1 | 0.21 ± 0.07 | −26.5 ± 0.4 | 95.5 ± 2.4 | 28.03 ± 1.9 | 99.8 ± 3.3 | 0.19 ± 0.07 | −23.7 ± 0.8 | 89.62 ± 4.7 | 25.86 ± 0.9 |
Data are represented as mean ± SEM (n = 6)
(PDI polydispersity index, ZP zeta potential, EE entrapment efficiency, DL drug loading, S-NLCs sesamol-loaded nanostructured lipid carriers)